JAMA Internal Medicine: Papillomavirus Infections Topic Collection http://archinte.jamanetwork.com/ en-us Sat, 01 Dec 2012 00:00:00 GMT Tue, 01 Jan 2013 00:50:24 GMT Silverchair editor@archinte.jamanetwork.com webmaster@archinte.jamanetwork.com Safety Against Cervical Precancer and Cancer Following Negative Human Papillomavirus and Papanicolaou Test Results in Human Immunodeficiency Virus–Infected Women http://archinte.jamanetwork.com/article.aspx?articleID=1162168 Mon, 09 Jul 2012 00:00:00 GMT Castle PE, Fetterman B, Poitras N, et al. <span class="paragraphSection">The American Cancer Society (ACS) first recommended cotesting (cervical cytologic and human papillomavirus [HPV] DNA testing) as an acceptable alternative to routine cervical cytologic testing alone for cervical cancer screening in 2002. The ACS recommendations included extending the screening interval to not less than 3 years for those women who tested negative for both tests (“negative cotest”).</span> 172 13 1041 1043 10.1001/archinternmed.2012.1744 http://archinte.jamanetwork.com/article.aspx?articleID=1162168